Table 3.
ORa estimates related to positivity to SARS-CoV-2 among those who performed at least 1 swab (N=12,793), stratified by gender and age group (1 model for each variable).
| Variable and category | Male | Female | |||
|
|
Age 45-59 years (n=2847, 22.3%), OR (95% CI)b | Age 60-74 years (n=3114, 24.3%), OR (95% CI)b | Age 45-59 years (n=4477, 35.0%), OR (95% CI)b | Age 60-74 years (n=2355, 18.4%), OR (95% CI)b | |
| CCIc | |||||
|
|
0 | Reference | Reference | Reference | Reference |
| 1 | 0.97 (0.87-1.10) | 1.07 (0.96-1.19) | 1.01 (0.93-1.10) | 1.05 (0.94-1.17) | |
| 2-3 | 0.79 (0.66-0.95)d | 0.86 (0.77-0.97)d | 0.98 (0.84-1.14) | 0.93 (0.81-1.07) | |
| 4+ | 0.60 (0.42-0.86)d | 0.79 (0.67-0.95)d | 0.67 (0.41-1.09) | 0.91 (0.71-1.17) | |
| Oncological disease | 0.72 (0.55-0.95)d | 0.63 (0.53-0.73)d | 0.82 (0.66-1.02) | 0.70 (0.57-0.87)d | |
| Cardiovascular disease | 0.80 (0.68-0.94)d | 0.91 (0.82-1.01) | 0.89 (0.77-1.04) | 1.02 (0.89-1.16) | |
| Respiratory disease | 0.89 (0.73-1.09) | 0.88 (0.76-1.01) | 0.82 (0.67-1.02) | 1.05 (0.89-1.25) | |
| Myocardial infarction | 0.83 (0.62-1.12) | 0.84 (0.72-0.98) | 0.58 (0.34-0.99)d | 1.10 (0.84-1.43) | |
| Heart failure | 0.46 (0.22-0.98)d | 0.78 (0.59-1.04) | 0.84 (0.33-2.14) | 1.10 (0.74-1.65) | |
| Cerebrovascular disease | 0.95 (0.67-1.35) | 1.18 (0.99-1.41) | 0.83 (0.56-1.22) | 1.12 (0.90-1.41) | |
| Diabetes | 1.02 (0.86-1.20) | 1.25 (1.13-1.39)d | 1.16 (1.01-1.34)d | 1.11 (0.98-1.27) | |
aOR: odds ratio.
bEstimates adjusted for age and the month of the first swab.
cCCI: Charlson Comorbidity Index.
dSignificant estimates (95% confidence level).